Earning Forecast for Intel, Microsoft, Merck, Citigroup, Bristol Myers Squibb, and JPMorgan Chase
HONG KONG, June 4, 2013 /PRNewswire/ — EarningForecast.com has issued earnings forecast reports for the following US stocks: Intel (NASDAQ:INTC), Microsoft (NASDAQ:MSFT), Merck (NYSE:MRK), Citigroup (NYSE:C), Bristol Myers Squibb (NYSE:BMY), and JPMorgan Chase (NYSE:JPM).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Intel Corporation (NASDAQ:INTC): By the end of trading session, Intel (NASDAQ:INTC) shares rose 3.95% to US$25.24 with more than 74.49 million shares traded, compared to its average volume of 43.77 million shares. Intel pushes its latest CPU named Haswell, which can increases 50% more battery life than previous models. Later this week, many PC manufactures will release their new devices with the chip at Computex show. Observing comprehensive analysis of Intel could help investors avoid big lost in investment. Check INTC earnings forecast report below.
Read Full Report: http://www.earningforecast.com/PR/060413A/INTC/Intel.pdf
Microsoft Corporation (NASDAQ:MSFT): Microsoft (NASDAQ:MSFT) shares began the trading session with a price of US$34.92. When day-trade ended, the stock finally lifted US$0.69 (or 1.98%) to US$35.59. The stock traded 51.26 million shares in the last trading session, compared to its daily average of 58.42 million shares. Through the last trading session, the share reached a new 52-week high of US$35.63. The company shareholders had about 33.25% gain this year. Investors may want to find out where Microsoft will go from here. Observe comprehensive MSFT earnings forecast report here.
Read Full Report: http://www.earningforecast.com/PR/060413A/MSFT/Microsoft.pdf
Merck & Co., Inc. (NYSE:MRK): The share of Merck (NYSE:MRK) began the trading session with a price of US$48.93. When day-trade ended, the stock price soared 3.75% to US$48.45. The stock traded 37.99 million shares in the last trading session, heavier than its daily average of 18.19 million shares. The share reached a new 52-week high of US$49.36 within the last trading session. Do you think Merck will go on? Do you think now is a good time to buy the stock? Investors could check MRK earnings forecast report here.
Read Full Report: http://www.earningforecast.com/PR/060413A/MRK/Merck.pdf
Today EarningForecast.com also observed abnormal trade volume for the following companies; Check out the consensus earnings forecast reports below:
Citigroup Inc (NYSE:C):
Read Full Report: http://www.earningforecast.com/PR/060413A/C/Citigroup.pdf
Bristol Myers Squibb Co. (NYSE:BMY):
Read Full Report: http://www.earningforecast.com/PR/060413A/BMY/BristolMyersSquibb.pdf
JPMorgan Chase & Co. (NYSE:JPM):
Read Full Report: http://www.earningforecast.com/PR/060413A/JPM/JPMorganChase.pdf
EarningForecast.com focuses on tracking and monitoring company Earnings Data for top market movers in US stocks market. EarningForecast.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit: EarningForecast.com/disclaimers/index.php for details.